Skip to main content
. 2010 Apr 8;3:69–91. doi: 10.2147/ijgm.s8184

Figure 1.

Figure 1

Least squares mean change in the composite daytime nasal symptoms score and its components during a 6-week trial of montelukast versus placebo in patients with perennial allergic rhinitis. Baseline scores are shown above the bars. aP < 0.001; bP < 0.05. Error bars represent SE. Reproduced with permission from Patel P, Philip G, Yang W, et al Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2005; 95(6):551–557.72 Copyright © 2005 American College of Allergy, Asthma and Immunology.